To The Moon

Oracle reached an agreement with Department of War to deploy Oracle AI capabilities on classified cloud networks.Deal targets use of generative AI, agentic AI across warfighting, intelligence, enterprise operations.Oracle cited 10 US government-dedicated cloud regions supporting classified levels up to Top Secret, Special Access Programs.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oracle Corporation published the original content used to generate this news brief on May 01, 2026, and is solely responsible for the information contained therein.

UnitedHealth Group's comeback got a serious boost when it scored an earnings beat a couple of weeks ago. Now, it's being added to Goldman Sachs' U.S. Conviction List -- Director's Cut, an acclaimed rundown of Buy-rated stocks.Goldman likes the healthcare company's plans to get smaller in Medicare Advantage, calling it a "shrink to grow" story.Medicare Advantage, the federally subsidized health insurance program for seniors, is central to UnitedHealth's business and comprises about 40% of its revenue. But the company stumbled last year, tripped up by rising medical costs and changes to how the government reimburses private insurers.This year, Goldman notes, UnitedHealth plans to reduce its Medicare Advantage enrollment by 1.3 million members and decrease membership by about 10% in its value-based care Optum Health business, which provides medical services to Medicare plan members.As profitability in the market bottoms out, analyst Scott Fidel sees a setup for a "sustained positive profi

A class action lawsuit has been filed against Oracle Corporation and certain senior executives, alleging securities fraud following a significant stock drop in December 2025. The complaint claims Oracle misled investors after reporting lower-than-expected revenue growth, higher-than-expected capital expenditures, and negative free cash flow exceeding $10 billion, which led to an 11% decline in the company's stock price. The lawsuit is pending in the U.S. District Court for the District of Delaware, and investors have until April 6, 2026, to seek appointment as lead plaintiff.